Literature DB >> 28847266

Independent Relationship between Serum Osteocalcin and Uric Acid in a Cohort of Apparently Healthy Obese Subjects.

Giovanni De Pergola1, Vito A Giagulli2, Nicola Bartolomeo3, Federica Gaeta1, Antonella Petruzzella1, Edoardo Guastamacchia4, Vincenzo Triggiani4, Franco Silvestris1.   

Abstract

BACKGROUND: It is generally accepted that serum osteocalcin (OC) is a reliable marker of bone formation, while the role of serum uric acid (UA) in bone metabolism is still debated. However, recent studies have shown that endogenous UA within the normal range may exert a positive effect in bone formation by means of its antioxidant role in both sexes. To date, no studies have been carried out in obese subjects aiming to study the relationship between serum OC and UA, given that obesity is considered as a risk factor for osteoporosis and fracture and, at the same time, for cardiovascular events.
OBJECTIVES: Our search purpose was to verify the relationship between endogenous levels of OC and serum UA in a cohort of obese subjects without any metabolic or chronic diseases (i.e. hypertension, renal failure, diabetes mellitus, etc.).
MATERIALS AND METHODS: One hundred and twenty one obese subjects (93 women and 28 men) were enrolled for this study. Serum OC and UA were assessed and compared with demographic characteristics, clinical and biochemical parameters (age, body mass index (BMI), blood pressure, waist circumference, serum lipids and glycaemia).
RESULTS: Serum OC was directly and independently correlated with circulating UA in our population of obese subjects, while neither BMI, age, serum lipids, fasting glycaemia nor gender showed a statistically significant correlation with endogenous plasma levels of OC.
CONCLUSION: The positive effect determined by serum OC in bone metabolism of our obese subjects might be partly due to the antioxidant properties that normal plasma UA levels exert at bone tissue level. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Body Mass Index (BMI); Osteocalcin; blood pressure; bone metabolism; obesity; uric acid

Mesh:

Substances:

Year:  2017        PMID: 28847266     DOI: 10.2174/1871530317666170825164415

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

1.  Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men.

Authors:  L D'Elia; A Giaquinto; F P Cappuccio; R Iacone; O Russo; P Strazzullo; F Galletti
Journal:  J Endocrinol Invest       Date:  2019-11-05       Impact factor: 4.256

2.  Effects of a Low Carb Diet and Whey Proteins on Anthropometric, Hematochemical, and Cardiovascular Parameters in Subjects with Obesity.

Authors:  Giovanni De Pergola; Roberta Zupo; Luisa Lampignano; Silvia Paradiso; Isanna Murro; Annagrazia Cecere; Nicola Bartolomeo; Marco M Ciccone; Gianluigi Giannelli; Vincenzo Triggiani
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

3.  Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway.

Authors:  Xing Zhou; Xingchun Wu; Luhui Qin; Shunyu Lu; Hongliang Zhang; Jinbin Wei; Lixiu Chen; Luhui Jiang; Yani Wu; Chunxia Chen; Renbin Huang
Journal:  Drug Des Devel Ther       Date:  2020-07-07       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.